Health Care · Pharmaceutical Preparations · NYSE · CIK 310158 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $152.55 · Day +2.39% · Mkt cap $376.4B · P/E (FY) 21.0× · 1Y +81.8% · Off 52W high −1.3% · Vol (1Y) 30.4% Price2023-08-21 → 2026-08-21 MRK close: $110 on 2023-08-21 to $153 on 2026-08-21. Split-adj closes · 240 of 6,696 · price returnⓘ At a glance | Short interest1.1% of sh out | | Days to cover3.3d | | 13F net flow (QoQ)+0.13% | | Top-10 13F concentration47.3% | | Next report (est.)2026-11-08 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)21.0× | | Sales (TTM)$66.57B | | Earnings (TTM)$3.17B | | ROE36.9% | | Net margin28.1% | | Debt / equity0.94× | | EPS growth 3Y8.4% | | Sales growth 3Y3.1% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+46.0% | | 1Y+81.8% | | 3Y+51.5% | | 5Y+125.9% | | 10Y+239.4% | | Since incept. (ann.)+7.0% |
Total return · from 2000-01-03ⓘ Risk | Ann. volatility (1Y)30.4% | | Ann. volatility (3Y)26.4% | | Sharpe (1Y)2.19 | | Sharpe (3Y)0.66 | | Max drawdown (1Y)−11.4% | | Max drawdown (3Y)−43.4% | | Beta (3Y vs SPY)0.04 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 225.8M | $27.2B | 9.13% | +3.1% | | VANGUARD CAPITAL MANAGEMENT LLC | 161.0M | $19.4B | 6.51% | new | | STATE STREET CORP | 119.3M | $14.5B | 4.83% | −0.6% | | WELLINGTON MANAGEMENT GROUP LLP | 84.3M | $10.1B | 3.41% | −2.5% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 67.3M | $8.1B | 2.72% | new | | GEODE CAPITAL MANAGEMENT, LLC | 59.6M | $7.1B | 2.41% | −0.8% | | JPMORGAN CHASE & CO | 53.0M | $6.3B | 2.14% | +81.4% | | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 49.8M | $6.0B | 2.01% | +2.5% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-04 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-04 | −$0.54 | −130.7% | $16.61B | +5.1% | | 2026-03-31 | 2026-04-30 | −$1.72 | −185.6% | $16.29B | +4.9% | | 2025-12-31 | 2026-02-03 | $1.19 | −20.1% | $16.40B | +5.0% | | 2025-09-30 | 2025-10-30 | $2.32 | +87.1% | $17.28B | +3.7% |
As-reported XBRL · next 2026-11-08 est.ⓘ Segment mixFY2025 (ended Dec 2025) US 39% · Non Us 30% · EMEA 16% · Latin America 4% · Asia Pacific 3% geographic · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
